Parkinson's disease

(Alpha-synuclein and Parkinson's Disease, n.d.). Parkinson's disease researchers take great interest in it because it is a major constituent of Lewy bodies, which are protein clumps that are the pathological hallmark of Parkinson’s disease (Alpha-synuclein and Parkinson's Disease, n.d.). Researchers work to characterize the protein's role in Parkinson’s and its potential as a target for neuroprotective therapies (Alpha-synuclein and Parkinson's Disease, n.d.). For a very small subset of…

Wellbeing Just as the right diet and medications are key to living well with Parkinson’s disease (PD), maintaining emotional health also is essential. Your emotional wellbeing is vital to your physical health. A PD diagnosis can bring a flood of emotions for the patient, as well as family members. Successfully navigating those feelings, whether anger, sadness, grief or even denial, is important. Stress can make Parkinson’s disease (PD) symptoms worse. By focusing on your strengths, nurturing…

Nerve cells and neurons are the base segments of the nervous system, they send and receive impulses, with the help of dopamine, a compound present in the body as a neurotransmitter. When dealing with parkinson's disease, dopamine producing nerve cells begin to die off. Basal ganglia is responsible for ensuring smooth movement, but when dopamine is not stimulated adequately, basal ganglia are affected, which causes imbalances, slowness and stiffness. Overall…

Treatments for this disease vary. There are various ways to control the progression of symptoms, and some have even brought back quality of life for a long period of time. However, there is no ‘cure’ to parkinson’s. One of the most common treatment option is prescription drugs. These include, but are not limited to: Artane, Azilect, Cogentin, Comtan, Dopar, Larodopa, Mirapex, Neupro, Requip, Sinemet, and Tasmar. Each of these are designed to maintain motor function and prolong the more negative…

COMPARISON PAPER Science, fact or fiction, you be the judge. The two articles that I chose to write about are; Few mild-to-moderate parkinson’s disease patients suffer from malnutrition, yet almost one third are at risk (IOS Press BV, September.11, 2014). Also Slim quick diet pill. In the first article about Parkinson’s disease (PD) it basically is stating that patients are at risk for malnutrition and poor nutrition (IOS Press BV, september. 11, 2014). The reasoning behind this…

Neurodegenerative diseases are distinguished by progressive neuronal cell loss with clear patterns in disparate disorders such as Alzheimer’s, Parkinson and Huntington’s. They are responsible for around 4% of fatalities worldwide and 5% of disability-adjusted life years from a non-communicable disease (NCD). Neurodegenerative disorders are not only caused by genetics but protein misfolding disorders and protein degradation by the proteasome system. These disorders continue to increase as well as…

An example of the limitation is deep brain stimulation for patients with Parkinson’s resulting a lack of controlled data, mismatch evidence, insufficient medication effect in the clinical practice. Another instance of the limitation in the EBM are the patients with non-motor symptoms of PD. Some areas such as constipation, anxiety, fatigue, insomnia, sexual dysfunction urinary incontinence have not been thoroughly discussed in the research for symptoms of PD patients which can be considered as…

concentrating. Parkinson’s disease is a very controlling chronic disease. “Parkinson's disease is a degenerative neurologic disease” (Parkinson’s disease Overview). Parkinson’s disease is a tragic chronic disease. Like many other chronic diseases, Parkinson’s disease takes a toll on the person and the person’s family. Parkinson’s disease is a disease that gets worse with time. It slowly takes over the nervous system and begins to control the brain. One with Parkinson’s disease may…

with Parkinson’s disease, but it is important to note what it is, how it affects an individual, what the treatment options are, and how individuals cope with this disease. Parkinson’s Disease is a disease involving the death of brain cells called neurons in which causes the movements of the body to become uncontrollable. In this paper, Parkinson’s disease, its symptoms, secondary factors, population affected, causes, treatment, and therapy approaches will be thoroughly discussed. Parkinson’s…

AIM: Sarcopenia has been defined as an involuntary loss of skeletal muscle mass and strength and/or function. The presence of sarcopenia in patients with Parkinson’s disease (PD) may have prognostic effects and may be mistaken for poor therapeutic control of PD. We aimed to evaluate sarcopenia in patients with PD. METHODS: One hundred non-demented PD patients, and 95 healthy subjects were included in the study. Avarage-Muscle mass, weight, bone mass, fat mass, basal metabolism rate (BMR), body…